Skip to navigation

2017 Press Releases


Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
October 12, 2017
SteadyMed Receives Notice of Allowance for its European Patent Relating to Enhanced Reduction of Infusion-Site Pain
September 28, 2017
SteadyMed Submits Type A Meeting Request Package to FDA
August 31, 2017
SteadyMed Receives Refusal to File Letter from FDA for Trevyent® New Drug Application
August 11, 2017
SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
August 09, 2017
SteadyMed to Present at the 2017 Wedbush PacGrow Healthcare Conference
July 31, 2017
SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs
June 30, 2017
SteadyMed Submits New Drug Application for Trevyent®
June 13, 2017
SteadyMed to Present at the 2017 JMP Securities Life Sciences Conference
May 26, 2017
SteadyMed Raises Additional Capital from Key Institutional Shareholder
May 12, 2017
SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 02, 2017
SteadyMed Receives USPTO Notice of Allowance for Patent Related to Key PatchPump® Technology
April 21, 2017
SteadyMed Raises $30 Million in Private Placement
April 05, 2017
SteadyMed Completes Clinical Validation Study of Trevyent®
March 31, 2017
SteadyMed Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent
March 29, 2017
SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results
January 09, 2017
SteadyMed Outlines Strategic Goals and Priorities for 2017 and Provides Update on Trevyent Launch Plans


E-mail Alerts RSS Printer Friendly Version E-mail this page Share Page